Amarin Corp Plc (AMRN)

[MedResCollab]

rafunrafun,

This is yet another logical fallacy. If individual A. makes argument B. based on evidence C., and argument B. is later proven wrong, and subsequently individual A. makes argument D. based on evidence E., that remains as yet unproven, it is illogical to conclude that argument D., which relies on evidence E., is faulty, because argument B. was proven wrong. Further, it is a compounded error to then assert all arguments by individual A. are wrong because (s)he made argument B., which was proven wrong, ergo all subsequent arguments by individual A. are de facto wrong.

Once again, you must present counter-evidence to our current arguments regarding Amarin Corp., including our evidence the REDUCE-IT results are confounded, and FDA will likely not approve the efficacy supplement without supplementary data proving mineral oil has no effect on multiple cardiac medications, and also our evidence that the patents covering Vascepa are all either invalidated for lacking novelty and/or for obviousness, or are otherwise not infringed by ANDA filers. You have not even attempted in the slightest to do so. That is your prerogative, but it should be pointed out.

Regards,
-MRC